Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. - Wikidata - awgldk - TriplyDB

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

http://www.wikidata.org/entity/Q37054976

about

Gangliosides for the treatment of diabetic peripheral neuropathy Standards of medical care in diabetes--2012 Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic Mesenchymal Stem Cells as a Prospective Therapy for the Diabetic Foot Type 1 diabetes through the life span: a position statement of the American Diabetes Association Mitochondrial hormesis and diabetic complications Standards of medical care in diabetes--2013 Urogenital Autonomic Dysfunction in Diabetes.Therapeutic management of diabetic kidney disease.Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort Standards of medical care in diabetes--2010.Diabetic neuropathy: mechanisms to management Molecular mechanisms of diabetic vascular complications Diabetes regulates mitochondrial biogenesis and fission in mouse neurons.Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy.Diabetes education: the experiences of young adults with type 1 diabetes Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Diabetes: glycaemic control in type 1 Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes.Puerarin prevents high glucose-induced apoptosis of Schwann cells by inhibiting oxidative stress.Standards of medical care in diabetes--2011.The pancreas in human type 1 diabetes.Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?Mechanisms of disease: the oxidative stress theory of diabetic neuropathy Diabetic neuropathy: new strategies for treatment.Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC Prevention and early detection of vascular complications of diabetes Autonomic nervous system function in type 2 diabetes using conventional clinical autonomic tests, heart rate and blood pressure variability measures Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes.Selection of aptamers specific for glycated hemoglobin and total hemoglobin using on-chip SELEX.Pharmacological treatment of diabetic peripheral neuropathy.Early diabetic neuropathy: triggers and mechanisms.Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.Multisystemic therapy compared to telephone support for youth with poorly controlled diabetes: findings from a randomized controlled trial A Genome-wide Association Study Provides Evidence of Sex-specific Involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) With Diabetic Neuropathic Pain Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model

P2860

Q24198249-1118509B-41B5-429F-AF9F-C918AF4999C3 Q24632533-4FDBF7B3-3566-479A-946D-57215D09AC93 Q26739745-E5034319-EACC-40C0-9DE9-CA861CA76A21 Q28074810-6C44091C-785E-4055-91F1-674D3B839575 Q28242092-298816CA-B71B-46E4-82C4-6EAC3DFED818 Q28388387-8712F46A-EA19-4311-A94B-BFC5B46E8F05 Q29620309-C7929766-39C3-4DDF-B40E-D9E472FC8F0B Q30244250-071D3318-9438-499D-A4A2-771E2F2B20BF Q30362729-CDA99422-D865-4C8E-9617-0C705E0712C8 Q30436948-D63E4E1D-868A-4664-9A71-43AF30BF5083 Q33554238-C63A21A2-77AA-4987-BE45-155D57252DE9 Q33554384-8316F5D0-08FC-4D56-95EC-C78C34A9361C Q33558421-31AFC778-917A-4D6D-9CB3-9763E8089EAE Q33571558-06632475-C8AB-4573-8423-4E283BDA1515 Q33701317-4AD8A81E-FFF7-47AC-BAF6-D9AC956A666B Q33785157-4F054408-56F3-403D-BFAA-165057D96AAA Q33804684-75B88742-A5A0-41C5-BCF7-8F0D175F10CC Q33891703-AA187AF1-BC12-42C8-9C62-BDD772D84EA1 Q34313633-0FE9B735-FD9C-4A3D-9D18-B96088266B4C Q34358231-A92224B0-4559-4D18-9367-BA9F4327B568 Q34425055-9377BB65-377C-4D83-825F-3451D7E5C201 Q34496850-F1049E28-0C7D-4F3A-B5E2-948836A39946 Q34533154-AFABFED3-FDA3-424D-9474-1DAE7748574C Q34553052-614B2FCE-98B9-43F2-AAFF-065E88E7A0AA Q34641965-DE8E5333-32ED-459C-9076-6A9B5084035F Q34762475-BC2CB5B1-C9B3-4254-9D37-C5CE2296859B Q34842230-CD80AECD-0D69-4AE2-B060-D6BBD2C379B0 Q34873090-95D19BD1-2158-47AF-86F2-F35443889208 Q35004314-D3D3FAF1-B545-4EA9-8082-7F8B4826C073 Q35013431-60B73B21-8EE0-4423-BE5D-34EFED3DE811 Q35165905-4976E350-6826-4C61-B0C4-59B222823A4B Q35184731-B94B258A-25F7-441A-80F5-FE7CF4E64CE5 Q35434962-0559DCEC-5C35-48B2-A05A-74708D98177A Q35669997-0C0061A5-2C36-4F89-9B8D-4E8F8E1A6642 Q35691425-0053F6FE-CA28-4E1A-A3CC-E598FDC51FB4 Q35893638-0F7DE45F-37EE-4D66-8BA1-5B5119889D36 Q35896615-F5281754-17DC-46DF-9937-031B04B18E6F Q36236701-22AEA734-3B11-4E2A-8EC5-F50B6DE74499 Q36251379-7A38DD46-60E1-49A1-8B10-BA1D53AC8172 Q36535440-C46F776F-6F10-40A4-A18D-F5C68CDF764A

P2860

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

http://www.wikidata.org/entity/Q37054976

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neuropathy among the diabetes ...... years after trial completion.

@en

Neuropathy among the diabetes ...... years after trial completion.

@nl

type

label

Neuropathy among the diabetes ...... years after trial completion.

@en

Neuropathy among the diabetes ...... years after trial completion.

@nl

prefLabel

Neuropathy among the diabetes ...... years after trial completion.

@en

Neuropathy among the diabetes ...... years after trial completion.

@nl

P1433

Q37054976-8603293C-EB3C-4525-BFAA-9FBAE12C97BE

P1476

Q37054976-B4B7F0BE-DF05-478A-A630-A20F5BCE7446

P2093

Q37054976-1632433C-DB58-4E28-8863-53F0888EDF27

Q37054976-2F385B5E-ABE1-4B73-8C50-2A6CEA9AFCD9

Q37054976-3F43141C-8E42-4FBF-8C85-E02C055AAE0E

Q37054976-49FB729A-C241-4976-B67B-57014CE2FFF6

Q37054976-763316EA-4CC2-4357-BA22-14927303C876

Q37054976-8C5176E4-4705-4B3C-AACA-45CFC2D4A63C

Q37054976-B5407D96-F8D0-47C5-B469-1DF897795814

Q37054976-C23ED7BA-9CE0-4B0A-A807-2E9F785F3D99

Q37054976-F619F2D6-30B7-4EB8-837F-0DE2717E4D06

P2860

Q37054976-114B1E83-89E6-41FB-BA3C-5EAC4C4885D4

Q37054976-18AE7B93-E135-4394-901E-915DA73C72DB

Q37054976-227AC251-B031-4C39-871F-2031E92E53BC

Q37054976-90DDFC49-5EF0-4C60-88DA-5832E4BEAE11

Q37054976-BC7F79A9-99B8-4702-B0C5-A3707BEF10F5

Q37054976-D1BD1044-0B5C-4FE6-8341-7AF304D74051

Q37054976-FF2C781D-4C41-4B3D-88C3-D90CF3082211

P304

Q37054976-4CAA39E6-2272-458D-89CB-BF5B873A194B

P31

Q37054976-30130F9A-3934-4424-93D1-0BBEB0BD474C

P356

Q37054976-2512E058-B698-48C2-AD0A-C202CD3CBDA5

P407

Q37054976-BD456355-C63D-433D-8FA8-C5118468EE92

P433

Q37054976-3360E7AD-5B96-4011-8750-135A54C8A392

P478

Q37054976-B8B32AA9-394D-48DF-A039-15E852D476D0

P577

Q37054976-5DB78585-3A76-43E9-8019-0715772025B5

P5875

Q37054976-E2F2A1C2-5DBB-4FCA-A9FA-C26A444A1EA2

P698

Q37054976-6CFB0C45-B417-47AD-8C5D-DDE226B74F53

P932

Q37054976-9778B3E1-B892-48E3-BD1A-07F7FC1D8888

P356

DIACARE.29.02.06.DC05-1549

P1433

P1476

Neuropathy among the diabetes ...... years after trial completion.

@en

P2093

Barbara Waberski

http://www.w3.org/2001/XMLSchema#string

Catherine L Martin

http://www.w3.org/2001/XMLSchema#string

DCCT/EDIC Research Group

http://www.w3.org/2001/XMLSchema#string

Douglas A Greene

http://www.w3.org/2001/XMLSchema#string

Eva L Feldman

http://www.w3.org/2001/XMLSchema#string

James Albers

http://www.w3.org/2001/XMLSchema#string

Martin J Stevens

http://www.w3.org/2001/XMLSchema#string

Patricia Cleary

http://www.w3.org/2001/XMLSchema#string

William H Herman

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes.

Vascular risk factors and diabetic neuropathy.

P304

340-344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIACARE.29.02.06.DC05-1549

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7329698

http://www.w3.org/2001/XMLSchema#string

P698

16443884

http://www.w3.org/2001/XMLSchema#string

P932

2622720

http://www.w3.org/2001/XMLSchema#string